One, Myriad Medical
Myriad Medical is China's largest and the world's leading medical devices and solutions provider, the main products cover three major areas: life information and support, in vitro diagnostics and medical imaging. The company realized operating revenue of 16.064 billion yuan in the first three quarters of 2020, a year-on-year increase of 29.76%, and net profit of 5.363 billion yuan, a year-on-year increase of more than 46%.
Two, Tigermed
January-September 2020 to achieve revenue of 2,300,466,325.04 yuan, an increase of 13.27%; attributable to shareholders of listed companies, net profit of 1,318,020,419.28 yuan, an increase of more than 149%. Among them, the net profit attributable to shareholders of listed companies in the third quarter of 319,214,160.00 yuan, an increase of more than 81% year-on-year.
Three, Inventec Medical
January-September 2020 to achieve revenue of 8,944,921,086.99 yuan, an increase of more than 486%; attributable to shareholders of listed companies, net profit of 4,372,579,432.27 yuan, an increase of more than 3,376%. Of which the third quarter earnings of 2,451,278,060.35 yuan, an increase of 4,363.39% over the same period last year.
Four, Zhende medical
Zhende medical main business is the production, research and development and sales of medical dressings. Zhende medical January to September 2020 to achieve revenue of 8,116,660,488.11 yuan, an increase of more than 531%; attributable to shareholders of the listed company's net profit of 2,097,753,320.69 yuan, an increase of more than 2105%.